Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Combined alloreactive CTL cellular therapy with prodrug activator gene therapy in a model of breast cancer metastatic to the brain.

Hickey MJ, Malone CC, Erickson KL, Lin A, Soto H, Ha ET, Kamijima S, Inagaki A, Takahashi M, Kato Y, Kasahara N, Mueller BM, Kruse CA.

Clin Cancer Res. 2013 Aug 1;19(15):4137-48. doi: 10.1158/1078-0432.CCR-12-3735.

2.

Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.

Kang W, Seol HJ, Seong DH, Kim J, Kim Y, Kim SU, Nam DH, Joo KM.

Oncol Rep. 2013 Sep;30(3):1101-6. doi: 10.3892/or.2013.2584.

PMID:
23828015
3.

Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.

Kang NH, Hwang KA, Yi BR, Lee HJ, Jeung EB, Kim SU, Choi KC.

Cancer Gene Ther. 2012 Jun;19(6):412-9. doi: 10.1038/cgt.2012.15.

PMID:
22498724
4.

Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.

Garcia-Sanchez F, Pizzorno G, Fu SQ, Nanakorn T, Krause DS, Liang J, Adams E, Leffert JJ, Yin LH, Cooperberg MR, Hanania E, Wang WL, Won JH, Peng XY, Cote R, Brown R, Burtness B, Giles R, Crystal R, Deisseroth AB.

Blood. 1998 Jul 15;92(2):672-82.

5.

Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector.

Takahashi M, Valdes G, Hiraoka K, Inagaki A, Kamijima S, Micewicz E, Gruber HE, Robbins JM, Jolly DJ, McBride WH, Iwamoto KS, Kasahara N.

Cancer Gene Ther. 2014 Oct;21(10):405-10. doi: 10.1038/cgt.2014.38.

6.

Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases.

Joo KM, Park IH, Shin JY, Jin J, Kang BG, Kim MH, Lee SJ, Jo MY, Kim SU, Nam DH.

Mol Ther. 2009 Mar;17(3):570-5. doi: 10.1038/mt.2008.290.

7.

Adenovirus-mediated tissue-targeted expression of the CDglyTk gene for the treatment of breast cancer.

Su GQ, Su G, Huang ZH.

Mol Med Rep. 2012 Aug;6(2):321-9. doi: 10.3892/mmr.2012.925.

PMID:
22641384
9.

Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma.

Kaliberov SA, Market JM, Gillespie GY, Krendelchtchikova V, Della Manna D, Sellers JC, Kaliberova LN, Black ME, Buchsbaum DJ.

Gene Ther. 2007 Jul;14(14):1111-9.

PMID:
17495948
10.

In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma.

Breton E, Goetz C, Kintz J, Accart N, Aubertin G, Grellier B, Erbs P, Rooke R, Constantinesco A, Choquet P.

C R Biol. 2010 Mar;333(3):220-5. doi: 10.1016/j.crvi.2009.12.012.

PMID:
20338540
11.
13.

Thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell apoptosis in breast cancer cells.

Kong H, Tao L, Qi K, Wang Y, Li Q, Du J, Huang Z.

Oncol Rep. 2013 Sep;30(3):1209-14. doi: 10.3892/or.2013.2562.

PMID:
23799574
14.

Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.

Wang C, Natsume A, Lee HJ, Motomura K, Nishimira Y, Ohno M, Ito M, Kinjo S, Momota H, Iwami K, Ohka F, Wakabayashi T, Kim SU.

Cancer Gene Ther. 2012 Nov;19(11):796-801. doi: 10.1038/cgt.2012.63.

PMID:
23018623
15.

[Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].

Kong H, Huang ZH, Li Q, Yang LC, Yu JL, Li Z.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jun;28(6):907-10. Chinese.

16.
17.

Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model.

Yin D, Zhai Y, Gruber HE, Ibanez CE, Robbins JM, Kells AP, Kasahara N, Forsayeth J, Jolly DJ, Bankiewicz KS.

Cancer Gene Ther. 2013 Jun;20(6):336-41. doi: 10.1038/cgt.2013.25.

18.

Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.

You MH, Kim WJ, Shim W, Lee SR, Lee G, Choi S, Kim DY, Kim YM, Kim H, Han SU.

J Gastroenterol Hepatol. 2009 Aug;24(8):1393-400. doi: 10.1111/j.1440-1746.2009.05862.x.

PMID:
19486256
19.

Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.

Chang JW, Lee H, Kim E, Lee Y, Chung SS, Kim JH.

Neurosurgery. 2000 Oct;47(4):931-8; discussion 938-9.

PMID:
11014433
20.

A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells.

Jiang J, Wei D, Sun L, Wang Y, Wu X, Li Y, Fang Z, Shang H, Wei Z.

Oncol Rep. 2014 Feb;31(2):781-7. doi: 10.3892/or.2013.2898.

PMID:
24317390
Items per page

Supplemental Content

Support Center